恆指升幅擴至近300點 保險及手機藥股領漲
美國前副總統拜登於「超級星期二」民主黨總統提名初選結束報捷大勝桑德斯,加上環球各主要央行陸續減息應對新冠肺炎疫情對經濟造成影響,繼聯儲局後,加拿大央行也大幅減息50點子為11來最大,以及美國ISM服務業指數與私企新增職位均勝預期,紓緩市場對疫情衝擊經濟憂慮,美股三大指數昨晚在醫保板塊及科技半導體受捧急漲推動下收復前晚所有失地有餘急彈3.8%-4.5%,道指跑贏曾重越27,100。不過,美股期貨全面回吐約0.6%,限制亞太區股市升幅,除台港滬澳及新西蘭依次升1%-1.9%外,餘下升幅均少於1%。恆指扭轉連續兩天反覆受壓勢,今早高開126點或0.5%,升幅擴至288點或1.1%,報26,510,成交額485億元。藍籌股普遍向好,兩大藥股走勢最強,石藥(01093.HK)及中生製藥(01177.HK)曾齊漲半成,高見19.06及12.44元,現造18.94元及12.32元,分別續升4.4%及回升4.6%,前者股價一舉升破4條平均線。費城半導體指數及蘋果股價昨晚急彈4.9%及4.6%,手機股舜宇(02382.HK)及瑞聲(02018.HK)分別續升2.6%及回升4%,分別報131.7元及52.55元,前者股價突破20天及100天線(130.5元);重磅股騰訊(00700.HK)升1.3%報399.2元。防守性較強公用股中電(00002.HK)/電能實業(00006.HK)、蒙牛(02319.HK)、創科(00669.HK)及萬洲(00288.HK)續升逾2%-3.5%,分別報83.6元/56.75元、29.3元、67.15元及8.39元。金融股以保險股表現最好,尤其是友邦(01299.HK)及中國平安(02318.HK)分別報76.4元及88.8元,回升1.8%及2.1%,後者重越10天線(88.2元)。匯控(00005.HK)隨外圍同業股價由逾三年半低位彈0.9%報51.8元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.